Article History
Received: 30 April 2023
Accepted: 16 June 2023
First Online: 8 July 2023
Declarations
:
: The authors declare no competing interests.
: N/A.
: N/A.
: AO received speaker honoraria from Bristol-Myers Squibb, Ono Pharmaceutical, Daiichi Sankyo, and Taiho Pharmaceutical Co. KY received speaker honoraria from Chugai Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Merck Serono, Taiho Pharmaceutical Co., Takeda, and Eli Lilly; a consultant fee from Takeda Pharmaceutical Co. Ltd.; honoraria from Tsumura Co. Ltd., Nihon Kayaku Co. Ltd., and Chugai Pharmaceutical Co. Ltd; research grants from Sumitomo Dainippon Pharma, Gilead Sciences, MSD, Boehringer Ingelheim, Daiichi Sankyo, and Chugai Pharmaceutical Co. Ltd; and speaker honoraria, research grants, and scholarship grants from Ono Pharmaceutical, Yakult Honsha Co., Ltd., and Sanofi.